Royal Bank of Canada’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.4M | Buy |
|
|||||
|
2025
Q2 | $6.82M | Buy |
|
|||||
|
2025
Q1 | $59K | Sell |
|
|||||
|
2024
Q4 | $176K | Sell |
|
|||||
|
2024
Q3 | $273K | Buy |
|
|||||
|
2024
Q2 | $125K | Buy |
|
|||||
|
2024
Q1 | $46K | Sell |
|
|||||
|
2023
Q4 | $302K | Buy |
|
|||||
|
2023
Q3 | $66K | Buy |
|
|||||
|
2023
Q2 | $64K | Buy |
|
|||||
|
2023
Q1 | $63K | Sell |
|
|||||
|
2022
Q4 | $136K | Buy |
|
|||||
|
2022
Q3 | $10K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $90K | Sell |
|
|||||
|
2021
Q4 | $490K | Buy |
|
|||||
|
2021
Q3 | $209K | Sell |
|
|||||
|
2021
Q2 | $247K | Buy |
|
|||||
|
2021
Q1 | $89K | Buy |
|
|||||
|
2020
Q4 | $10K | Buy |
|